Skip to content
DataLookout
Menu

NCT05970783

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

StatusUnknown
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Minor Primary completion date changed from estimate of Feb 2024 to Mar 11, 2024
    • Study completion date: Nov 2024 to Apr 2025
    • Site contact updated
    v2
  3. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Pain disappearance rate after 12 weeks of treatment
Timeframe: 12 Weeks

Secondary (7)

Pain disappearance rate after 4 and 8 weeks of treatment
Change of weekly average Visual Analogue Scale (VAS) score from baseline after 12 weeks of treatment
The area under the VAS score-time curve
McCormick Scale
General quality of life (Short Form-12) scale
Show 2 moreShow less
Disease efficacy evaluation
Adverse events (AEs)

Arms and interventions

Jincaopian Tablets groupExperimental

Patients receive Jincaopian Tablets 0.6g/day for 12 weeks.

Placebo groupPlacebo comparator

Patients receive a placebo 0.6g/day for 12 weeks.

Drugs: Jincaopian Tablets

Other: Placebo

Sites

1 site in 1 country

  • Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical UniversityBeijing, Beijing Municipality, China